Dr. Ayed O. Ayed, MD

Dr. Ayed practices at Cancer Specialists of North Florida in Jacksonville, Florida.

Dr. Ayed's NPI, 1639428782, was assigned on September 5, 2012. Dr. Ayed graduated from University of Jordan Faculty of Medicine in 2011. Dr. Ayed holds Florida license ME135547.

Dr. Ayed's primary practice is Cancer Specialists of North Florida, at 7015 A C Skinner Pkwy, Jacksonville, FL 32256 in Duval County. The practice phone is (904) 363-2113.

Dr. Ayed's primary practice is Cancer Specialists of North Florida in Jacksonville, Florida. Dr. Ayed is also affiliated with Ascension St. Vincent's Riverside. The medical group on file is Cancer Specialists of North Florida. Dmand AI also links Dr. Ayed to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ayed practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ayed's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ayed is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Ayed's licenses on file in 2 states: Florida and Minnesota.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphoma among the conditions Dr. Ayed treats.

CMS data shows 22,065 Medicare services from Dr. Ayed across 22 procedure codes in 2024, for 304 Medicare patients. Medicare paid $141,544 for them.

CMS counts 304 Medicare patients who saw Dr. Ayed in 2024. The largest group is 75 to 84, with 145 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ayed's median patient age at 69, with 61% women.

In 2024, Dr. Ayed wrote 1,772 Medicare Part D claims for 269 patients. 73% of them were for generic drugs. CMS names the drug for 1,398 of them, across 44 drugs with 11 or more claims each, at $3,672,483 in total drug cost. In 2023, CMS named 882 claims across 30 drugs.

Dr. Ayed accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 9 papers to Dr. Ayed, published from 2010 to 2023. 2018 was the busiest year, with 2. The most frequent topics are Leukemia, Lymphocytic, Chronic, B-Cell, Pyrimidines and Adenine. Dr. Ayed's most frequent co-authors are Ian Winchester Flinn, MD, Tara Michelle Graff, DO and Jeremy S. Abramson, MD.

Dmand AI links Dr. Ayed to 3 clinical trials. 3 are still active or recruiting. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell and Leukemia, B-Cell. Loxo Oncology, Inc. sponsors the most, 3. Open Payments lists research payments to Dr. Ayed that name 3 trials.

CMS Open Payments shows 364 general payments to Dr. Ayed from 48 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 75% of the total. Genentech, Inc. paid the most, $14,900. It also lists 19 research payments totaling $52,672 from 2021 to 2025, naming 3 clinical trials.

Dr. Ayed graduated from University of Jordan Faculty of Medicine in 2011. Dr. Ayed is a member of AMA, ASCO, ASH and FMA.

Dr. Ayed is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.